{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:47:59Z","timestamp":1789829279002,"version":"4.0.1"},"reference-count":49,"publisher":"American Society of Hematology","issue":"11","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The mutational landscape of peripheral T-cell lymphoma (PTCL) is being revealed through sequencing of lymph node samples, but there has been little work on the mutational load that is present in cell-free DNA (cfDNA) from plasma. We report targeted sequencing of cfDNA from PTCL patients to demonstrate c.50G&amp;gt;T (p.Gly17Val) in RHOA as previously described in angioimmunoblastic T-cell lymphoma (AITL) and a group of PTCL not otherwise specified (NOS) but also detect novel mutations at c.73A&amp;gt;G (p.Phe25Leu) and c.48A&amp;gt;T (p.Cys16*) of exon 2, which were confirmed by Sanger sequencing. In a group of AITL and PTCL-NOS analyzed by droplet digital polymerase chain reaction, 63% (12\/19) showed c.50G&amp;gt;T (p.Gly17Val), 53% (10\/19) c.73A&amp;gt;G (p.Phe25Leu), and 37% (7\/19) c.48A&amp;gt;T (pCys16*). Sequencing of lymph node tissue in 3 out of 9 cases confirmed the presence of c.73A&amp;gt;G (p.Phe25Leu). Inspection of individual sequencing reads from individual patients showed that a single RHOA allele could contain &amp;gt;1 mutation, suggesting haplotypes of mutations at RHOA. Serial sampling showed changes to RHOA mutational frequency with treatment and the apparent occurrence of clones bearing specific haplotypes associated with relapse. Therefore, sequencing of RHOA from cfDNA has revealed new mutations and haplotypes. The clinical significance of these findings will need to be explored in clinical trials, but liquid biopsy might have potential for guiding treatment decisions in PTCL.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019001075","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T15:31:23Z","timestamp":1591111883000},"page":"2392-2403","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":12,"title":["Multiple mutations at exon 2 of RHOA detected in plasma from patients with peripheral T-cell lymphoma"],"prefix":"10.1182","volume":"4","author":[{"given":"Barbara","family":"Ottolini","sequence":"first","affiliation":[{"name":"Leicester Cancer Research Centre and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Nawaz","sequence":"first","affiliation":[{"name":"Leicester Cancer Research Centre and"},{"name":"Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9128-3533","authenticated-orcid":false,"given":"Christopher S.","family":"Trethewey","sequence":"first","affiliation":[{"name":"Leicester Cancer Research Centre and"},{"name":"Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7014-5481","authenticated-orcid":false,"given":"Sami","family":"Mamand","sequence":"first","affiliation":[{"name":"Leicester Cancer Research Centre and"},{"name":"Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Allchin","sequence":"first","affiliation":[{"name":"Leicester Cancer Research Centre and"},{"name":"Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9333-5296","authenticated-orcid":false,"given":"Richard","family":"Dillon","sequence":"first","affiliation":[{"name":"Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King\u2019s College London, London, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5288-8898","authenticated-orcid":false,"given":"Paul A.","family":"Fields","sequence":"first","affiliation":[{"name":"Department of Haematology, Guy\u2019s and St. Thomas\u2019 Hospital, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Ahearne","sequence":"first","affiliation":[{"name":"Leicester Cancer Research Centre and"},{"name":"Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8914-0370","authenticated-orcid":false,"given":"Simon D.","family":"Wagner","sequence":"first","affiliation":[{"name":"Leicester Cancer Research Centre and"},{"name":"Ernest and Helen Scott Haematology Research Institute, University of Leicester, Leicester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"issue":"25","key":"2020060211305617100_B1","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","article-title":"Peripheral T-cell lymphoma","volume":"117","author":"Foss","year":"2011","journal-title":"Blood"},{"issue":"25","key":"2020060211305617100_B2","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"11","key":"2020060211305617100_B3","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2020060211305617100_B4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","article-title":"Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets","volume":"117","author":"Piccaluga","year":"2007","journal-title":"J Clin Invest"},{"issue":"1","key":"2020060211305617100_B5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Couronn\u00e9","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"2020060211305617100_B6","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"issue":"11","key":"2020060211305617100_B7","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2020060211305617100_B8","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3324\/haematol.2014.113696","article-title":"Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas","volume":"100","author":"Manso","year":"2015","journal-title":"Haematologica"},{"issue":"5","key":"2020060211305617100_B9","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2015.357","article-title":"Recurrent activating mutations of CD28 in peripheral T-cell lymphomas","volume":"30","author":"Rohr","year":"2016","journal-title":"Leukemia"},{"issue":"2","key":"2020060211305617100_B10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"issue":"2","key":"2020060211305617100_B11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"issue":"12","key":"2020060211305617100_B12","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","article-title":"Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling","volume":"33","author":"Watatani","year":"2019","journal-title":"Leukemia"},{"issue":"20","key":"2020060211305617100_B13","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"13","key":"2020060211305617100_B14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/cncr.28676","article-title":"Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network","volume":"120","author":"Herrera","year":"2014","journal-title":"Cancer"},{"issue":"7655","key":"2020060211305617100_B15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","article-title":"Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution [published correction appears in Nature. 2018;554(7691):264]","volume":"545","author":"Abbosh","year":"2017","journal-title":"Nature"},{"issue":"1","key":"2020060211305617100_B16","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1038\/s41467-018-05327-w","article-title":"Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer [published correction appears in Nat Commun. 2019;10(1):552]","volume":"9","author":"Nong","year":"2018","journal-title":"Nat Commun"},{"issue":"9","key":"2020060211305617100_B17","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00277-017-3038-2","article-title":"Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma","volume":"96","author":"Sakata-Yanagimoto","year":"2017","journal-title":"Ann Hematol"},{"issue":"364","key":"2020060211305617100_B18","doi-asserted-by":"crossref","first-page":"364ra155","DOI":"10.1126\/scitranslmed.aai8545","article-title":"Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA","volume":"8","author":"Scherer","year":"2016","journal-title":"Sci Transl Med"},{"issue":"14","key":"2020060211305617100_B19","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1182\/blood-2016-05-719641","article-title":"Diffuse large B-cell lymphoma genotyping on the liquid biopsy","volume":"129","author":"Rossi","year":"2017","journal-title":"Blood"},{"issue":"8","key":"2020060211305617100_B20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41408-018-0111-6","article-title":"Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort","volume":"8","author":"Bohers","year":"2018","journal-title":"Blood Cancer J"},{"issue":"7447","key":"2020060211305617100_B21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature12065","article-title":"Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA","volume":"497","author":"Murtaza","year":"2013","journal-title":"Nature"},{"issue":"28","key":"2020060211305617100_B22","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1200\/JCO.2018.78.5246","article-title":"Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma","volume":"36","author":"Kurtz","year":"2018","journal-title":"J Clin Oncol"},{"issue":"10","key":"2020060211305617100_B23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"issue":"7467","key":"2020060211305617100_B24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12625","article-title":"The causes and consequences of genetic heterogeneity in cancer evolution","volume":"501","author":"Burrell","year":"2013","journal-title":"Nature"},{"issue":"13","key":"2020060211305617100_B25","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","article-title":"Analysis of circulating tumor DNA to monitor metastatic breast cancer","volume":"368","author":"Dawson","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"2020060211305617100_B26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nmeth.1419","article-title":"Target-enrichment strategies for next-generation sequencing","volume":"7","author":"Mamanova","year":"2010","journal-title":"Nat Methods"},{"issue":"2","key":"2020060211305617100_B27","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1373\/clinchem.2016.261834","article-title":"Next generation sequencing of circulating cell-free DNA for evaluating mutations and gene amplification in metastatic breast cancer","volume":"63","author":"Page","year":"2017","journal-title":"Clin Chem"},{"issue":"12","key":"2020060211305617100_B28","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1158\/1078-0432.CCR-15-2470","article-title":"Circulating cell-free tumor DNA analysis of 50 genes by next-generation sequencing in the prospective MOSCATO trial","volume":"22","author":"Jovelet","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"5","key":"2020060211305617100_B29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","article-title":"Mutational processes molding the genomes of 21 breast cancers","volume":"149","author":"Nik-Zainal","year":"2012","journal-title":"Cell"},{"issue":"22","key":"2020060211305617100_B30","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1021\/ac202028g","article-title":"High-throughput droplet digital PCR system for absolute quantitation of DNA copy number","volume":"83","author":"Hindson","year":"2011","journal-title":"Anal Chem"},{"issue":"6","key":"2020060211305617100_B31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients [published correction appears in Nat Med. 2017;23(8):1004]","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"issue":"10","key":"2020060211305617100_B32","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3324\/haematol.2011.061507","article-title":"Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA","volume":"97","author":"Delfau-Larue","year":"2012","journal-title":"Haematologica"},{"issue":"9","key":"2020060211305617100_B33","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41591-019-0561-9","article-title":"Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers [published correction appears in Nat Med. 2019;25(12):1949]","volume":"25","author":"Parikh","year":"2019","journal-title":"Nat Med"},{"issue":"7","key":"2020060211305617100_B34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/bloodadvances.2017015164","article-title":"Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma","volume":"2","author":"Delfau-Larue","year":"2018","journal-title":"Blood Adv"},{"issue":"5","key":"2020060211305617100_B35","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood-2015-06-644948","article-title":"Variegated RHOA mutations in adult T-cell leukemia\/lymphoma","volume":"127","author":"Nagata","year":"2016","journal-title":"Blood"},{"issue":"12","key":"2020060211305617100_B36","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1038\/s41375-018-0197-7","article-title":"Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies","volume":"32","author":"Bagratuni","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"2020060211305617100_B37","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41467-018-04001-5","article-title":"Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma","volume":"9","author":"Manier","year":"2018","journal-title":"Nat Commun"},{"issue":"15","key":"2020060211305617100_B38","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1158\/1078-0432.CCR-19-0624","article-title":"Clinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non-small cell lung cancer","volume":"25","author":"Leighl","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2020060211305617100_B39","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/s41416-018-0293-5","article-title":"Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer","volume":"119","author":"Garc\u00eda-Foncillas","year":"2018","journal-title":"Br J Cancer"},{"issue":"9","key":"2020060211305617100_B40","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/2159-8290.CD-17-0146","article-title":"Analysis of circulating cell-free DNA identifies multiclonal heterogeneity of BRCA2 reversion mutations associated with resistance to PARP inhibitors","volume":"7","author":"Quigley","year":"2017","journal-title":"Cancer Discov"},{"issue":"8","key":"2020060211305617100_B41","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nm.3915","article-title":"Toward understanding and exploiting tumor heterogeneity","volume":"21","author":"Alizadeh","year":"2015","journal-title":"Nat Med"},{"issue":"3","key":"2020060211305617100_B42","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/path.5376","article-title":"Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell","volume":"250","author":"Yao","year":"2020","journal-title":"J Pathol"},{"issue":"4","key":"2020060211305617100_B43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jtho.2016.11.2235","article-title":"Capture-based targeted ultradeep sequencing in paired tissue and plasma samples demonstrates differential subclonal ctDNA-releasing capability in advanced lung cancer","volume":"12","author":"Mao","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"5","key":"2020060211305617100_B44","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1182\/blood-2015-12-683458","article-title":"Opposite RHOA functions within the ATLL category","volume":"127","author":"Ishikawa","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2020060211305617100_B45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ccell.2018.01.001","article-title":"RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis","volume":"33","author":"Cort\u00e9s","year":"2018","journal-title":"Cancer Cell"},{"issue":"9","key":"2020060211305617100_B46","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2017-11-818617","article-title":"RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice","volume":"132","author":"Ng","year":"2018","journal-title":"Blood"},{"issue":"8","key":"2020060211305617100_B47","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1172\/JCI92026","article-title":"Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis","volume":"127","author":"Zang","year":"2017","journal-title":"J Clin Invest"},{"issue":"26","key":"2020060211305617100_B48","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"18","key":"2020060211305617100_B49","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1158\/1078-0432.CCR-18-0143","article-title":"False positive plasma genotyping due to clonal hematopoiesis","volume":"24","author":"Hu","year":"2018","journal-title":"Clin Cancer Res"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/11\/2392\/1743392\/advancesadv2019001075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/11\/2392\/1743392\/advancesadv2019001075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T15:31:47Z","timestamp":1591111907000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/11\/2392\/460598\/Multiple-mutations-at-exon-2-of-RHOA-detected-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,6,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019001075","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]}}}